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Abstract
BACKGROUND: Ovarian fibrothecoma is a rare, benign, sex cord-stromal neoplasm, with a typically unilateral 
location in the ovary, characterized by mixed features of both fibroma and thecoma. Ovarian fibrothecoma is 
uncommon tumor of gonadal stromal cell origin accounting for 3-4% of all ovarian tumours.
CASE PRESENTATION: We presented a rare case of a 46-year-old patient with recurrent menorrhagia in the 
past two years with no previous medical, surgical or gynecological history. She underwent two times curettage 
procedures. At the admission to hospital ultrasonography showed a homogenous solid right ovarian mass of size 
2.5 cm x 3.5 cm. Endometrial curettage revealed simple hyperplasia of the endometrium. Diagnostic evaluation and 
surgical management are discussed along with a brief review of the literature. Total abdominal hysterectomy with 
bilateral salpingo-oophorectomy was carried out.  Histopathology confirmed fibrothecoma of the ovary, proliferative 
endometrium with hyperplasia without atypia and multiple uterine fibroids.
CONCLUSION: In all patients presenting with recurrent menorrhagia and adnexal tumor the possibility of a granulosa 
cell tumor must be kept in mind during evaluation.
Introduction
Ovarian fibromas/fibrothecomas belong to 
sex cord-stromal tumors. They are solid benign tumors 
of the ovary, accounting for 1–4.7% of all ovarian 
neoplasms [1]. About 15% of affected patients develop 
endometrial hyperplasia (EH) and 20% are diagnosed 
with endometrial cancer [2]. In very rare cases has been 
reported the co-existence of this tumors with uterine 
fibroids [3], [4]. About 10%–15% of ovarian fibrothecomas 
can be combined with ascites; however, less than 1% are 
combined with both ascites and hydrothorax, known as 
Meigs syndrome which disappears spontaneously after 
the tumor be removed [5]. Histologically, fibromas are 
composed of variable amounts of collagen from entirely 
spindle, oval, or round cells. The comas resemble theca 
interna cells of the ovary and are composed of lipids. There 
is a large histological and immunohistochemical overlap 
between the two structures that resulted in the term 
“fibrothecoma” [6]. These tumors affect all age groups and 
in 70% of the cases, the patients are diagnosed as having 
Stage I lesions at presentation, contrary to the epithelial 
ovarian tumors where patients present with Stage III or IV 
disease [7]. The pre-operative diagnostic rate of ovarian 
granulose cell tumors is rather low due to its low incidence, 
diverse clinical syndromes, and the great differences 
existing in tumor size, shape, and internal components. It 
is, therefore, often misdiagnosed as uterine myoma. When 
the tumor size is large, with ascites or even hydrothorax, 
and an elevated cancer antigen 125 (CA 125) level, it 
is probably misdiagnosed as malignancy [8]. Here, we 
present a rare case of unilateral ovarian fibrothecoma in 
a 46-year-old woman who presented with premenopausal 
bleeding in the past 2 years.
Case Report
A 46-year-old premenopausal multiparous 
woman, with previous three normal vaginal deliveries, 
married, with no significant personal or family history, 
presented to gynecology department with recurrent 
uterine bleeding in the past 2 years. These symptoms 
were accompanied by lower abdominal pain and 
discomfort for the past 6 months’ duration. The 
abdominal pain was a dull ache in the right lower 
abdomen which propagated to the back.
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Pelvic examination revealed an enlarged 
anteverted uterus and a solid right ovarian mass of 
3–4 cm size which it was confirmed by pelvic ultrasound 
scan (Figure 1).
Figure 1: Ovarian fibrothecoma on ultrasound
Transvaginal ultrasound examination suggested 
the presence of a solid, movable, and non-homogenous 
echoic mass (3.5 × 2.8 cm) originated from the right 
ovary. It was a solid mass with an intact capsule. No 
pathologic findings within the left ovary were found. 
A multiple intramural uterine fibroids were identified 
(Figure 2). No ascites was detected. Liver and the other 
abdominal organs were normal. She did not notice a 
significant change in her body weight or appetite. Her 
blood pressure was 135/90 mmHg. Her respiratory and 
cardiovascular systems were normal. The history of the 
disease was for the past 2 years. She underwent 2 times 
curettage procedures, without improvement of bleeding.
Figure 2: Ultrasound image of uterine fibroids
The results seem EH without cellular atypia. 
She had already tried conservative treatment, which 
had not improved her symptoms. Papanicolaou test 
excluded any microscopic modification of the uterine 
cervix. Laboratory tests including carcinoembryonic 
antigen and α-fetoprotein were normal. CA 125 level 
was in normal range.
 Treatment options were discussed with the 
patient after which she decided for hysterectomy.
A staging laparotomy was done. There was no 
ascites intraoperatively. Uterus appeared enlarged with 
multiple small fibroids. The right ovary was about 4 × 
3 cm in size, solid in appearance with an attached solid 
tumor formation. The left ovary appeared normal. Pouch 
of Douglas, omentum, intestinal surface, peritoneum, 
and other pelvic and abdominal viscera were free of 
tumor deposits. Retroperitoneal lymph nodes were not 
enlarged. Total abdominal hysterectomy with bilateral 
salpingo-oophorectomy was performed.
Histopathological examination detected 
enlarged uterus with endometrial polyposis and 
numerous myometrial leiomyomas. Uterus was 11 × 
3.5 cm with multiple fibroids of 1.5 × 1 cm in size and 
one biggest fibroid 8 × 6.5 cm in size in the anterior 
wall and uterine fundus; the endometrium was 1 cm 
in thickness and showed inactive glands with foci of 
hyperplasia without atypia and hemorrhage within 
the endometrial cavity. The myometrium was 2 cm in 
thickness and was unremarkable microscopically. The 
right ovary was 2.5 × 3.5 cm size with an attached 
solid tumor formation 2 × 2.5 cm with a small grainy 
surface with yellow and white areas (Figure 3). Its cut 
section was solid, grayish-white to grayish-yellow with 
cystic areas (Figure 4).
Figure 3: Macroscopic view of the tumor mass
The left ovary was normal measuring 2.5 
× 2 cm. Microscopic images of the tumor revealed 
uniform and cytologically bland-looking spindle cells 
with centrally placed nuclei without atypia arranged in 
fascicles (Figure 5). Most of the tumor cells had centrally 
placed oval to slightly angulated nuclei and a moderate 
amount of pale vacuolated cytoplasm (Figure 6).
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day. She is now on follow-up and doing well for the past 
8 months’ post-surgery with no complaints.
Discussion
Fibrothecomas are rare benign ovarian tumors 
extending from solid fibromas to lipid-rich thecomas 
and constituting the most common sex cord-stromal 
tumors of the ovary [9]. These account for about 4% of 
all ovarian tumors. The clinical presentation of ovarian 
fibrothecoma is relatively nonspecific such as pelvic 
and abdominal pain or distension; however, ovarian 
fibromas may be accompanied by two associations. 
The first is called Meigs syndrome (ovarian fibroma, 
hydrothorax, and ascites). The second association 
is with basal cell nevus syndrome (bilateral ovarian 
fibromas, multiple basal cell carcinoma of skin, and 
odontogenic keratocysts) [10]. We do not find any of 
these conditions in our patient. Fibrothecomas are 
usually benign, unilateral and occur commonly in old 
age [11]. They occur often in postmenopausal women 
with a peak incidence between 50 and 55 years of age. 
Our patient was in premenopausal age with irregular 
and rare menstrual cycles. This tumor produces 
estrogen, reason for EH, recurrence uterine bleeding, 
and early diagnosis. About 70% of tumors are hormone 
secreting [12]. The most common presentation in 
premenopausal and menopausal age group is abnormal 
uterine bleeding (53.7%). Either it could present as 
postmenopausal bleeding (27.5%), heavy or irregular 
menstruation (26.2%), or amenorrhea [13]. Our case 
was associated with intermitted vaginal bleeding, 
abdominal pain, and EH. When it comes to the most 
important prognostic factors of women diagnosed with 
ovarian granulosa cell tumors, it seems that prognosis 
is strongly influenced by the initial stage at diagnosis 
followed by the integrity of the ovarian capsule and 
the dimensions of the tumor [14]. In this case, the 
tumor size was small, without ascites, and with an 
intact capsule. Some studies reported benign ovarian 
thecoma associated with hydrothorax and elevated 
CA 125 tumor marker, which mimicked an ovarian 
malignancy [15], [16], [17]. In a study by Ramkumar 
et al., bilateral thecoma presented as premenopausal 
hirsutism with hyperandrogenism [18]. Pedunculated 
and intraligamentous leiomyomas, Brenner tumors, 
granulose cell tumors, and dysgerminomas should be 
considered as differential diagnosis [19]. Numanoglu 
et al. presented that there are no specific markers for 
accurate preoperative diagnosis of ovarian fibroma/
fibrothecoma. Depending on the menopausal status, 
serum CA-125 level, and ultrasonographic findings, 
risk of malignancy index scoring system does not 
aid clinicians in this issue either, with a high false-
positive rate and very love sensitivity [18]. The 
modality of treatment could be tumor excision alone, 
Figure  5:  The  fibrous  component  consists  of  cytologically  bland 
spindle cells arranged in fascicles. HE ×20
Figure 4: Cut surface of tumor with cystic change
Figure 6: The thecomatous component consists of polygonal cells 
with vacuolated cytoplasm. HE ×20
No capsular infiltration was seen.  Histopathological 
diagnosis was benign ovarian fibrothecoma. Uterine 
fibroids were composed predominantly of smooth 
muscle cells separated by variable amounts of fibrous 
connective tissue. Although there was no true capsule, 
well circumscribed and surrounded by a pseudocapsule.
Post-operative recovery was uneventful and 
the woman was discharged on the 7th post-operative 
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uni- or bilateral salpingo-oophorectomy with or without 
hysterectomy depending on the patient status, and the 
aggressiveness of the tumor [21], [22]. In the case that 
we present, total hysterectomy with bilateral salpingo-
oophorectomy was performed, because of women’s 
premenopausal age, multiple uterine fibroids, and right 
ovarian tumor mass.
Conclusion
This case shows that the hormonal changes 
caused by fibrothecoma can cause recurrent 
premenopausal uterine bleeding, because of the 
continuous EH. Gynecologists should be aware of this 
type of tumor considering the difficulties in diagnosis. 
Most of them are benign, with a good prognosis. 
Surgery is the preferred treatment for fibrothecoma, and 
the present study suggested that the patient accepts 
the hysterectomy and bilateral salpingo-oophorectomy 
to avoid endometrial cancer in postmenopausal age. 
Cystectomy only can be performed in young women in 
the reproductive period. The patient had good recovery 
post-surgery with no complications. On follow-up, she 
did not have any health problem and she is in a good 
condition.
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